For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...
This option is one of the key differences between Kisunla and Leqembi, which was administered throughout its clinical trials. So at USC, doctors have a weekly meeting to discuss how patients are ...
Her husband isn't sure if it made a difference. In 2020 ... That sort of uncertainty is common when it comes to Leqembi and Kisunla, two new Alzheimer's drugs approved since 2023.